Recent advances in UroLift: A comprehensive overview.

IF 1 Q4 UROLOGY & NEPHROLOGY

Turkish journal of urology Pub Date : 2022-01-01 DOI:10.5152/tud.2022.21149

Andrew Denisenko, Bhaskar Somani, Vineet Agrawal

{"title":"Recent advances in UroLift: A comprehensive overview.","authors":"Andrew Denisenko, Bhaskar Somani, Vineet Agrawal","doi":"10.5152/tud.2022.21149","DOIUrl":null,"url":null,"abstract":"Objective: Recent years have seen a steep rise in minimally invasive surgical therapy (MIST) for benign prostate hyperplasia (BPH). Prostatic urethral lift (UroLift) is a mechanical intervention aimed at reducing lower urinary tract symptoms, which affect patients with BPH.Material and methods: A narrative synthesis of all studies regarding UroLift is performed over the last decade, evaluating its impact on International Prostate Symptom Score (IPSS), quality of life (QoL), Qmax, Benign Prostate Hypertrophy Impact Index, and sexual health metrics.Results: The studies included have demonstrated significant improvements in the objective parameters measured. UroLift has a low side-effect profile and is comparable to transurethral resection of the prostate in QoL changes and is superior with respect to recovery time and ejaculatory function.Conclusion: Our findings suggest that UroLift may be an appropriate treatment for individuals undergoing treatment for BPH who are concerned with sexual and ejaculatory functions. More studies are needed to determine who is eligible for UroLift, as well as the long-term impact of UroLift on individuals with BPH.","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612739/pdf/tju-48-1-11.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish journal of urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/tud.2022.21149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 3

Abstract

Objective: Recent years have seen a steep rise in minimally invasive surgical therapy (MIST) for benign prostate hyperplasia (BPH). Prostatic urethral lift (UroLift) is a mechanical intervention aimed at reducing lower urinary tract symptoms, which affect patients with BPH.

Material and methods: A narrative synthesis of all studies regarding UroLift is performed over the last decade, evaluating its impact on International Prostate Symptom Score (IPSS), quality of life (QoL), Qmax, Benign Prostate Hypertrophy Impact Index, and sexual health metrics.

Results: The studies included have demonstrated significant improvements in the objective parameters measured. UroLift has a low side-effect profile and is comparable to transurethral resection of the prostate in QoL changes and is superior with respect to recovery time and ejaculatory function.

Conclusion: Our findings suggest that UroLift may be an appropriate treatment for individuals undergoing treatment for BPH who are concerned with sexual and ejaculatory functions. More studies are needed to determine who is eligible for UroLift, as well as the long-term impact of UroLift on individuals with BPH.

查看原文本刊更多论文

UroLift的最新进展:全面概述。

目的:近年来，良性前列腺增生(BPH)的微创手术治疗(MIST)急剧上升。前列腺尿道提升术(UroLift)是一种旨在减轻前列腺增生患者下尿路症状的机械干预方法。材料和方法:对过去十年关于UroLift的所有研究进行叙述性综合，评估其对国际前列腺症状评分(IPSS)、生活质量(QoL)、Qmax、良性前列腺肥大影响指数和性健康指标的影响。结果:所纳入的研究表明在测量的客观参数方面有显著的改善。UroLift副作用低，在生活质量变化方面与经尿道前列腺切除术相当，在恢复时间和射精功能方面优于经尿道前列腺切除术。结论:我们的研究结果表明，对于正在接受BPH治疗且与性功能和射精功能有关的个体来说，UroLift可能是一种合适的治疗方法。需要更多的研究来确定谁有资格使用UroLift，以及UroLift对BPH患者的长期影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Turkish journal of urology Medicine-Urology

CiteScore

2.10

自引率

0.00%

发文量

期刊介绍： The aim of the Turkish Journal of Urology is to contribute to the literature by publishing scientifically high-quality research articles as well as reviews, editorials, letters to the editor and case reports. The journal’s target audience includes, urology specialists, medical specialty fellows and other specialists and practitioners who are interested in the field of urology.